Lipocine Inc.

Ticker LPCN

Exchange NASDAQ More
Industry Drugs - Generic More
Sector Healthcare More

11-50 Employees
Based in Salt Lake City, Utah

Lipocine Inc. is a specialty pharmaceutical company developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies. Lipocine's clinical development pipeline includes three development programs LPCN 1021, LPCN 1111 and LPCN 1107. LPCN 1021, a novel oral prodrug of testosterone containing testosterone undecanoate, is designed…More

Visit website

REPORT RATINGS

4.8 / 5.0 (190)

Lipocine Inc. reports have an aggregate usefulness score of 4.8 based on 190 reviews.

Lipocine Inc.

Most Recent Annual Report

MOST RECENT 2022 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Lipocine Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.